Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-19-002873

Senior VP - CCO sold 12,000 shares at an average $9.75 ($116,940)

  • Senior VP - CCO acquired 12,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Powell Lynne · Senior VP - CCO

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2019-01-25 Exercise or conversion : show line 1 in the form +6,000 $3.22 $19,320 6,000 D
2019-01-25 Sale : show line 2 in the form −6,000 $9.60 $57,600 0 D
2019-01-28 Exercise or conversion : show line 3 in the form +4,000 $3.22 $12,880 4,000 D
2019-01-28 Sale : show line 4 in the form −4,000 $9.88 $39,520 0 D
2019-01-28 Exercise or conversion : show line 5 in the form +2,000 $3.22 $6,440 2,000 D
2019-01-28 Sale : show line 6 in the form −2,000 $9.91 $19,820 0 D
Open-market sales · 12,000 sh · avg $9.75 · $116,940

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2019-01-25 Exercise or conversion : show line 7 in the form Emp. Stock Option (Right to Buy) −6,000 85,427 D
2019-01-28 Exercise or conversion : show line 8 in the form Emp. Stock Option (Right to Buy) −4,000 81,427 D
2019-01-28 Exercise or conversion : show line 9 in the form Emp. Stock Option (Right to Buy) −2,000 79,427 D
Loading xslF345X03/form4.xml…